Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Anne Berberich(German Cancer Research Center), Wolfgang Wick(Hertie Institute for Clinical Brain Research)
Clinical Cancer Research
October 1, 2018
Cited by 77


Related Papers